Abstract
Antibiotics Radioactive labelling protocol
Experiments were initiated by transferring 200 ml of the Cefonicid was kindly provided by SmithKline Beecham (Italy). The compound was dissolved in phosphate-buffered frozen culture into fresh BHI broth containing 150 mCi of
[3H ]uracil (specific activity 1165.5 GBq/mmol; Du Pont de saline (PBS; 0.1 M, pH 7.4) immediately before each experiment. Antibiotic susceptibility testing was performed using Nemours, NEN Products, Italy). Following 4 h growth at 37°C, the radiolabelled klebsiellae were centrifuged several the standardized dilution method in Mueller Hinton broth ( Unipath) with an inoculum of 2×107 cfu/ml. times with BHI broth and resuspended in fresh medium to a final concentration of 2×107 cfu/ml, as confirmed by colony counts in triplicate.
Subjects Phagocytosis assay
All patients participating in this study gave their informed consent. Withdrawals were obtained from 45 healthy volunAliquots of 1.0 ml of klebsiellae (2×107 cfu) in RPMI 1640 teers, as controls, and from 55 immunocompromised patients with 10% FCS, were added to PMNs in sterile plastic tubes without any evidence of infection, followed at Dialysis Center (106cells) and then incubated at 37°C in a shaking water of the Ivrea Hospital (Italy). The subjects were divided in two bath. After incubation for 30-90 min the tubes were centrigroups. The first group included 31 patients on haemodialysis:
fuged at 160 g for 5 min; the pellet was then resuspended 17 males and 14 females ranging in age from 24 to 75 years with phosphate saline and centrifuged at 160 g for 5 min to (mean age 59.8±12 years). The mean time on dialysis was remove free klebsiellae. The cells were then resuspended in 61.8±53 months and the causes of uraemia were as follows:
1 ml of sterile distilled water for 5 min and 100 ml samples chronic glomerulonephritis (7 cases), nephroangiosclerosis (8 of this suspension were placed in scintillation fluid cases), polycystic kidney disease (3 cases), diabetic nephro-(Atomlight, NEN ) and counted by liquid scintillation specpathy (3 cases), chronic renal failure (7 cases), renal neoplasy trometry. Radioactivity was expressed as c.p.m./sample. The (1 case), and interstitial nephritis (2 cases). The mean normalpercentage phagocytosis at a given sampling time [12] was ized dose of dialysis per treatment ( KT/V=1.47±0.26) and calculated as: the protein catabolic rate (PCR=1.1) indicate an adequate dialysis prescription and nutrition. About 60% of the patients had secondary hyperparathyroidism (mean plasma levels of % phagocytosis= (c.p.m. in PMN pellet) (c.p.m. in total bacterial pellet) ×100 iPTH for all patients was 214 pg/ml ). The second group included 24 patients that had undergone renal transplantation: 17 males and 7 females, mean age 45.3±10 years. The mean time since transplantation was 55.9±49 months and primary renal diseases were as follows: chronic glomerulonephritis (9 Measurement of antimicrobial activity of PMNs cases), interstitial nephritis (5 cases), polycystic kidney disease (4 cases), diabetic nephropathy (2 cases), chronic renal failure Aliquots of 1 ml of klebsiellae (2×107 cfu) and PMNs in (2 cases), other (1 case). The mean serum creatinine at the sterile plastic tubes (106 cells) were incubated for 30 min in time of the study was 1.6±0.7 mg/dl. Post-transplant immuno-RPMI 1640 medium to allow phagocytosis to proceed. The suppressive treatment in 13 patients was cyclosporine A (CyA) PMN-bacteria mixtures were centrifuged at 160 g for 5 min and prednisone (P); in 9 patients CyA, P and azathioprine and washed with phosphate saline to remove any free extra-(AZA); in 1 patient CyA and AZA and in 1 patient AZA and P. cellular bacteria. Samples of the cells containing bacteria were lysed by adding sterile water and a viable count of intracellular klebsiellae was performed (T 0 ). The cells were
Polymorphonuclear granulocytes (PMNs)
then incubated further and at intervals (T x ) viable counts of surviving intracellular bacteria were measured in the same Peripheral venous blood was collected into sterile evacuated way. The PMN killing values were expressed as a Survival blood-collecting tubes containing lithium heparin (15 units Index (SI), calculated as the number of surviving micro-LH/ml blood) and settled at room temperature by gravity for organisms at 30 min (T 0 ) plus the number of surviving micro-30 min in 2.5% dextran (70 000 mol wt; Pharmacia S.p.A., organisms at T x divided by the number of surviving Italy) in normal saline (151 ratio). The leukocyte-rich micro-organisms at 30 min (T 0 ), as follows [13]: plasma supernatant was carefully layered on Ficoll-Paque (Pharmacia) and then centrifuged twice at 160 g for 15 min; to SI= (No. of cfu at T 0 +No. of cfu at T x ) (No. of cfu at T 0 ) . obtain pure PMNs, residual erythrocytes were lysed by hypotonic shock for 30 s in sterile distilled water and then centrifuged further. After being counted in a Bü rker cell counting According to this formula, if 100% killing took place, the chamber, the density of the PMNs was adjusted to 106 cells/ml ratio would be 1. in PBS supplied with 1% glucose and 0.1% human albumin (Sigma); the PMNs were then placed in sterile plastic tubes, treated with RPMI 1640 (Gibco Laboratories, USA), supple-Effect of cefonicid on PMN functions mented with 10% fetal calf serum (FCS; Gibco) and incubated for various periods at 37°C in a shaking water bath (150 rpm). The effects of cefonicid on PMN phagocytosis and intracellular killing of K. pneumoniae were investigated by incubating The viability was assayed by trypan blue exclusion and was greater than 95%; a viability test was carried out before and the bacteria and phagocytes at 37°C in a shaking water bath in the presence of half the minimal inhibitory concentration after each experiment. The time between the collection of blood and the beginning of the experiments did not exceed 3 h; the (MIC ) of the drug. Each test was carried out in quadruplicate and compared with control systems which contained no interval between PMNs harvest and the start of the experiments was less than 30 min.
antibiotics. the strain of K. pneumoniae (2×107 cfu/ml ) was 16 mg/ml.
aSignificantly different (P<0.01) from the controls.
The results shown in Table 1 indicate a diminished %=Percentage of initial bacterial population killed by PMNs in phagocytic efficiency with reduced phagocytosis and bac-presence of the antibiotic. tericidal capacity in PMNs from immunosuppressed subjects (haemodialysed patients and renal transplant phagocytosed klebsiellae by PMNs compared with recipients) when compared with the healthy controls. In controls. In the drug-free cultures the value of SI fact, PMNs from healthy subjects were able to engulf shifted from 1.43 at 30 min to 1.53 at 60 min and 1.69 between 30.6% and 20.22% of the bacteria in 90 min of at 90 min, which corresponds with a progressive observation; by contrast, PMNs from haemodialysed increase in the number of intracellular bacteria. The and renal transplant patients showed a diminished bac-presence of the antibiotic, however, produced a signiterial ingestion (25-17.4% and 19.4-15.5% respectively; ficantly higher killing effect (P<0.01) reducing the P<0.01). Moreover, considerable difference was found intracellular bacterial load by 89-90% ( Table 2) . among the bactericidal abilities of PMNs from haemo-A similar pattern was detected with phagocytes from dialysed patients, renal transplant recipients and healthy immunosuppressed subjects ( Tables 3 and 4 ). The subjects ( Table 1) . PMNs from uraemic patients were presence of half the MIC of cefonicid resulted in a able to kill 50% of the ingested klebsiellae until 30 min statistically significant increase in bacterial uptake only; after that time no killing occurred (SI>2). On the (P<0.01): in fact klebsiellae are phagocytosed at a contrary, the intracellular activity of PMNs from healthy rate that is~3-fold of that of the drug-free controls subjects was present for the entire 90 min of observation and similar to that observed in healthy subjects. The (57-31%).
bacterial killing of PMNs from immunosuppressed To determine the combined effect of phagocytes and subjects also increased in the presence of cefonicid, cefonicid, K. pneumoniae was added to half the MIC achieving the same values seen with PMNs from of the drug in the presence of human PMNs ( Table 2) . healthy subjects, whereas in drug-free systems phagoThe direct exposure of PMNs from healthy subjects, cytosed bacteria remained viable after 60 min: values and klebsiellae to sub-inhibitory concentrations of of SI were greater than 2, indicating intracellular cefonicid, significantly enhanced the phagocytosis, with survival. an increased percentage of engulfed bacteria after 30 min of incubation (61.23±2.8) and up to 90 min Discussion (76.88±5.8) compared with the control, drug-free system (30.6±2.6 and 20.22±2.1 respectively; P<0.01).
In order to be effective against Gram-negative bacteria a b-lactam must possess a broad antibacterial specCefonicid always enhanced intracellular killing of therefore explain the high incidence of infection among patients with severe renal failure and dialysis. When compared with the control, drug-free system, trum, penetrate the outer membrane, be resistant to blactamases, bind to the penicillin-binding proteins cefonicid, at half its MIC, significantly affected the activity of PMNs from healthy subjects against (PBPs) and have the desired pharmacological activity [14] . Among cephalosporins, cefonicid, a second gen-K. pneumoniae in vitro, resulting either in an increased percentage of ingested bacteria or in a reduced eration cephalosporin, possesses a broad spectrum of antibacterial activity, including against Gram-negative intracellular klebsiellae load (89-90%) during the 90 min of the experiment ( Table 2) . We speculate that anaerobes. The major advantages of this antibiotic over other cephalosporins include its high serum levels this enhancement is probably related to some cefonicidinduced phenotypic and biochemical changes in and an extended elimination half-life of~4.8 h which allows once-daily dosing [15] . According to the great K. pneumoniae, which facilitate phagocytosis and increase bacterial susceptibility to microbicidal PMNs majority of previous publications, cephalosporins, which are widely used in the treatment and prevention systems. These results corroborate our previous data showing that cefonicid is able to enhance the activities of bacterial infections, have no relevant effects on phagocyte functions [1] . However, in recent years, it of human macrophages both in vitro and ex vivo [19, 20] . has been reported that some cephalosporins are able to increase either phagocytosis or the killing of GramWhen cefonicid was added to PMNs from haemodialysed patients ( Table 3 ) and renal transplant recipients positive and Gram-negative bacteria by PMNs and mononuclear cells [16] [17] [18] . From our previous reports ( Table 4) a similar pattern was detected. The presence of half the MIC of the drug resulted in a significant [19, 20] it emerges that cefonicid combines good in vitro activity with the capacity to act in concert with increase in the bacterial uptake: klebsiellae were phagocytosed at a rate that was~3-fold that of the drugthe immune system in a way that potentiates the host's defences. In fact, at sub-inhibitory concentrations, free controls and similar to that observed in healthy subjects. The bacterial intracellular killing of PMNs cefonicid significantly increases in vitro and ex vivo bactericidal uptake by human macrophages and from immunosuppressed subjects also increased in the presence of cefonicid, achieving the values seen with intracellular activity towards phagocytosed K. pneu-PMNs from healthy subjects ( Table 2) Rev Infect Dis 1989; 11: 213-245 intracellular survival ( Tables 3, 4 T. Polymorphonuclear cells in chronic hemodialysis patients
